CoChat

Sarcopenia in the Older Adult With Cancer

Open access
Williams, Grant R., Dunne, Richard F., Giri, Smith, Shachar, Shlomit S., Caan, Bette J. · 2021 · Journal of Clinical Oncology
Cited by 248

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Article Tools REVIEW ARTICLES Caring for Older Adults With Cancer Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.21.00102 Journal of Clinical Oncology - published online before print May 27, 2021 PMID: 34043430 Sarcopenia in the Older Adult With Cancer Grant R. Williams , MD, MSPH1,2xGrant R. WilliamsSearch for articles by this author; Richard F. Dunne , MD3xRichard F. DunneSearch for articles by this author; Smith Giri , MD, MHS1,2xSmith GiriSearch for articles by this author; Shlomit S. Shachar , MD4,5xShlomit S. ShacharSearch for articles by this author; and Bette J. Caan, DrPH6xBette J. CaanSearch for articles by this author Show More 1Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL2Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL3Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY4Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel5Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel6Division of Research, Kaiser Permanente, Oakland, CA https://doi.org/10.1200/JCO.21.00102 First Page Full Text PDF Figures and Tables © 2021 by American Society of Clinical OncologyCONTEXTKey ObjectiveWhat is sarcopenia and why is it important in older adults with cancer?Knowledge GeneratedOlder adults with cancer are at increased risk of sarcopenia, and in turn, increased risk of chemotherapy toxicities, tumor progression, and mortality. Sarcopenia can be assessed using a variety of available methods and individuals with sarcopenia may benefit from targeted interventions consisting of exercise and/or nutrition.RelevanceDetecting sarcopenia in the growing number of older adults with cancer can aid in the assessment of the risk and benefit ratio of cancer treatments and assist in targeting interventions. Still, many important knowledge gaps persist in our understanding of sarcopenia in oncology and more research is needed.SUPPORTSupported in part by the National Cancer Institute of the National Institutes of Health (Grant No. K08CA234225, G.R.W.), the American Cancer Society (Grant No. ACS-18-162-59-IRG, G.R.W.) and the National Center for Advancing Translational Sciences of the National Institutes of Health (Grant No. KL2TR001999, R.F.D.).AUTHOR CONTRIBUTIONSConception and design: All authorsCollection and assembly of data: All authorsData analysis and interpretation: All authorsManuscript writing: All authorsFinal approval of manuscript: All authorsAccountable for all aspects of the work: All authorsAUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTERESTSarcopenia in the Older Adult With CancerThe following represents disclosure information provided by the authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).Grant R. WilliamsHonoraria: Carevive Systems, Cardinal HealthRichard F. DunneConsulting or Advisory Role: ExelixisSmith GiriHonoraria: CareVive, OncLiveResearch Funding: Carevive Systems, Pack HealthShlomit S. ShacharConsulting or Advisory Role: Novartis, Roche, Pfizer, LillyTravel, Accommodations, Expenses: Pfizer, RocheNo other potential conflicts of interest were reported.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.21.00102

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Metadata

Authors
Williams, G. R., Dunne, R. F., Giri, S., Shachar, S. S., & Caan, B. J.
Venue
Journal of Clinical Oncology
Published
2021-07-01
Volume
39
Issue
19
Pages
2068-2078
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W3165327555
Cited by
248
References
36
FWCI
18.93
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sarcopenia in the Older Adult With Cancer. https://app.cochat.ai/papers/10.1200/jco.21.00102
The paper
Williams, G. R., Dunne, R. F., Giri, S., Shachar, S. S., & Caan, B. J. (2021). Sarcopenia in the Older Adult With Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.21.00102

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.